SCHEMBL21943533

SCHEMBL21943533

Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Oc1cc(-c2ccncc2)nc2[nH]ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 8/20 0.58
▸ TEK Q02763 5/20 0.58
▸ PIKFYVE Q9Y2I7 1/20 0.57
▸ YES1 P07947 1/20 0.54
▸ MAP3K7 O43318 3/20 0.52
▸ MAP4K2 Q12851 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ MAPK14 Q16539 5/20 0.49
▸ KIT P10721 3/20 0.49
▸ CSF1R P07333 2/20 0.49
▸ BRAF P15056 2/20 0.48
▸ SRC P12931 3/20 0.47
▸ LCK P06239 2/20 0.47
▸ MAP4K4 O95819 1/20 0.47
▸ ABL1 P00519 1/20 0.47
▸ RAF1 P04049 1/20 0.47
▸ FES P07332 1/20 0.47
▸ LYN P07948 1/20 0.47
▸ FER P16591 1/20 0.47
▸ EPHA2 P29317 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21943518 0.94 PIKFYVE (0.64) KDRTEKPIKFYVEYES1MAP3K7
SCHEMBL21943532 0.92 PIKFYVE (0.68) KDRTEKPIKFYVEYES1MAP3K7
SCHEMBL21943068 0.88 PIKFYVE (0.54) KDRTEKPIKFYVEMAP3K7MAP4K2
SCHEMBL21943684 0.87 KDR (0.51) KDRTEKPIKFYVEPOLBMAPK14
SCHEMBL21943439 0.86 PIKFYVE (0.56) KDRTEKPIKFYVEMAP3K7MAP4K2
SCHEMBL21943516 0.86 PIKFYVE (0.75) KDRTEKPIKFYVEYES1MAP4K2
SCHEMBL22024705 0.85 PIKFYVE (0.75) KDRTEKPIKFYVEYES1MAP4K2
SCHEMBL21943451 0.85 KDR (0.58) KDRTEKYES1MAP4K2POLB
SCHEMBL30692257 0.84 MAP3K7 (0.70) KDRTEKPIKFYVEYES1MAP3K7
SCHEMBL12518525 0.84 MAP3K7 (0.70) KDRTEKPIKFYVEYES1MAP3K7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319322-B2 Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof XIAMEN UNIVERSITY (CN) 2022-05-03 — — US disclosed
EP-3647313-A1 SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Xiamen University (CN) 2020-05-06 — — EP disclosed
US-20200123162-A1 SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF XIAMEN UNIVERSITY (CN) 2020-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200123162-A1 SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF CYP4A11, CYP2D6, CYP3A43 KDR 2067/4885TEK 2462/4885PIKFYVE 2706/4885
US-11319322-B2 Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof CYP4A11, CYP2D6, CYP3A43 KDR 2067/4885TEK 2462/4885PIKFYVE 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback